Real-world outcomes in molecular subgroups for patients with advanced or recurrent endometrial cancer treated with platinum-based chemotherapy
Har du spørsmål om JEMPERLI for dine pasienter? Kontakt oss
Jemperli trademark is a registered trademark of the GSK group of companies.
© 2025 GSK group of companies or its licensor.